| Financial Year |
March 31 2023 |
| Monetary Funds |
150,202,729.45 |
| Held-for-trading Financial Assets |
310,000,000.00 |
| Notes Receivable |
62,378,712.38 |
| Accounts Receivable |
123,123,670.76 |
| Advances to Suppliers |
29,514,527.65 |
| Other Receivables |
6,679,152.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,678,180,589.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
239,891,821.54 |
| Total Current Assets |
2,831,667,193.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
2,001,401.25 |
| Fixed Assetes |
110,073,602.90 |
| Under-construction Projects |
27,836,746.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
49,526,875.81 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
253,865.45 |
| Deferred Income Tax Assets |
6,787,596.94 |
| Other Non-Current Assets |
954,920.00 |
| Sub-Total of Non-Current Assets |
206,595,666.90 |
| Total Assets |
3,038,262,860.32 |
| Short-Term Loans |
20,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
204,612,707.93 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,939,511.06 |
| Taxes Payable |
14,132,753.42 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,471,516.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,952,232.07 |
| Other Current Liabilities |
180,933,973.47 |
| Sub-Total of Current Liabilities |
1,454,908,763.50 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,463,080.24 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
16,915,414.15 |
| Total Liabilities |
1,471,824,177.65 |
| Paid-In Capital(Or Share Stock) |
143,705,250.00 |
| Capital Surplus |
472,755,236.51 |
| Surplus Reserve |
71,852,625.00 |
| LESS:Treasury Stock |
3,133,545.00 |
| Undistributed Profits |
880,994,425.05 |
| Minority Stockholder's Interest |
264,691.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,566,173,991.56 |
| Owner's Equity（Stockholder's Equity） |
1,566,438,682.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,038,262,860.32 |
